Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in NVCR — NovoCure Ltd

CIK 1596800 VANCOUVER, A1

Position in NVCR

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$7,810,275
-$740,295 QoQ
Shares Held
716,539
+8.4% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $142,528,439 across 16 Medical Devices names. NVCR ranks #4 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVCR
NovoCure Ltd
This page
716,539 $7,810,275

All Filings in NVCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,810,275 716,539
2025-12-31 $8,550,570 661,297
2025-09-30 $7,293,378 564,503
2025-06-30 $10,870,709 610,714
2025-03-31 $9,529,227 534,749
2024-12-31 $13,045,605 437,772
2024-09-30 $6,662,490 426,263
2024-06-30 $6,280,800 366,655
2024-03-31 $4,913,712 314,377
2023-12-31 $6,115,328 409,600
2023-09-30 $6,602,749 408,839
2023-06-30 $2,873,003 69,229
2023-03-31 $556,355 9,251
2022-06-30 $886,125 12,750